No abstract

The national medical research centers (NMRCs) play an important role in managing the quality of healthcare system and evaluating its resources within the supervised profiles in Russia. The lack of controlling resources within NMRCs limit the possibility for improving the efficiency of healthcare in supervised profiles. The electronic benchmarking system could’ve become such a tool for the controlling over medical organizations (MO). It would allow evaluating the activities of MO (for example, comparing the activities of the analyzed MO with the reference MO, or dynamics of changes in MO - historical benchmarking), finding and implementing the most effective methods for organization of work of MO and improving the quality of medical care provided to patients. The authors of the article describe the experience of development and implementation of benchmarking system in MO of the “Children's Oncology and Hematology” profile. Based on the initial results of the analysis, the following issues were identified: 1) absence of nutritive support algorithms (in 90 % of MO analyzed); 2) absence of children patient register for oncology and hematology (61 % of MO analyzed); 3) inability to organize radiation therapy service (55 % of MO analyzed); 4) deficit of surgeon operators in the field of “pediatric oncology” (42 % of MO analyzed); 5) absence of capacity for isolation of immunocompromised patients within intensive care units (39 % of MO analyzed). Thus, after analyzing with the use of electronic benchmarking tools, the primary problematics can be shown therefore the key problems requiring corrective measures by the MO management can be distinguished. The further dynamic assessment also allows evaluating of the effectiveness of the ‘work on bugs’ done.

The article presents a generalized analysis of information on benchmarking in the healthcare system of both the Russian Federation and foreign countries. The possibilities of benchmarking in the analysis, comparative evaluation of the methods used in the implementation of the functions of medical organizations are shown.

Neuroblastoma (NB) is considered as a model of risk-adapted therapy for malignant neoplasms in children. The use of a combination of prognostic factors, such as age, stage of the tumor process, histological variant, and molecular genetic profile of a tumor, makes it possible to identify three risk groups characterized by different intensity of therapy and prognosis. However, the stratification of patients with MYCN-amplified stage 1 NB into a certain risk group and, consequently, the choice of therapeutic tactics for patients in this group vary significantly in the protocols of large cooperative NB study groups. The study was approved by the Independent Ethics Committee and the Scientific Council of the Dmitry Rogachev National Medical